CHICAGO, April 20 (Reuters) - Boston Scientific Corp posted a profit for the first quarter, even as sales slipped, and raised its earnings per share forecast for the full year.
The medical products maker said on Wednesday that its first-quarter net earnings were $20 million, or 1 cent per share, compared with a loss of $1.59 million, or a loss of $1.05 per share, a year ago.
Sales were $1.92 billion in the quarter, down slightly from $1.96 billion a year ago.
(Reporting by Debra Sherman) Keywords: BOSTONSCIENTIFIC/ (debra.sherman@thomsonreuters.com; + 312 408 8134; Reuters Messaging: debra.sherman.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
The medical products maker said on Wednesday that its first-quarter net earnings were $20 million, or 1 cent per share, compared with a loss of $1.59 million, or a loss of $1.05 per share, a year ago.
Sales were $1.92 billion in the quarter, down slightly from $1.96 billion a year ago.
(Reporting by Debra Sherman) Keywords: BOSTONSCIENTIFIC/ (debra.sherman@thomsonreuters.com; + 312 408 8134; Reuters Messaging: debra.sherman.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.